Canada markets closed

XORTX Therapeutics Inc. (XRX.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
3.5400-0.1800 (-4.84%)
At close: 3:56PM EDT

XORTX Therapeutics Inc.

745 Thurlow Street
Suite 2400
Vancouver, BC V6E 0C5

Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. Allen Warren Davidoff Ph.D.Founder, CEO, Pres & Director192kN/A1960
Mr. Amar KeshriChief Financial OfficerN/AN/A1978
Nick RigopoulosDirector of CommunicationsN/AN/AN/A
Dr. David Sans M.B.A., Ph.D.Director of Corp. Devel.N/AN/AN/A
Dr. Stephen Haworth M.D., MRCPChief Medical OfficerN/AN/AN/A
Ms. Charlotte MayCorp. Sec.N/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.


XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, hypertension, insulin resistance, and diabetic nephropathy. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, an uric acid lowering agent used to treat patients infected with the coronavirus COVID-19 infection and suppression of acute kidney injury and associated health consequences; and XRx-221, a xanthine oxidase inhibitor candidates for the treatment of diabetic nephropathy. The company has a partnership with the Icahn School of Medicine to study the incidence of acute kidney injury and hyperuricemia in patients hospitalized with COVID-19. XORTX Therapeutics Inc. is headquartered in Vancouver, Canada.

Corporate Governance

XORTX Therapeutics Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.